ARTICLES BY THIS AUTHOR
- 3/26/2009
Pristiq: new antidepressant
Wyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. - 3/24/2009
New indication for Aclasta
Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. - 3/24/2009
CFP announces new president
Peter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009.